The global healthcare artificial intelligence market is undergoing a structural transition from speculative, early-stage point solutions to highly integrated, clinically validated enterprise platforms. In 2024 and 2025, the market expanded from $14.92 Billion to $21.66 Billion, with projections indicating a scale of $110.61 Billion by 2030, representing a compound annual growth rate of 38.6%. This rapid expansion is underpinned by a profound concentration of capital. Although

The European HealthTech sector has seen a surge of momentum, highlighted by a massive growth round addressing one of the industry's biggest bottlenecks: administrative fragmentation and clinical workflow inefficiencies. The European MedTech sector has experienced a highly active week, dominated by fallout from the MedTech Forum 2026 in Stockholm, a major legislative clash over AI regulation, and fresh structural updates designed to make Europe a more attractive market for med

The European healthcare technology and clinical artificial intelligence sectors have transitioned into an era of disciplined industrialisation. The speculative fragmentation and "growth-at-all-costs" investment thesis that characterized the zero-interest-rate policy era have been replaced by a rigorous focus on unit economics, real-world clinical evidence, and deep workflow integration. As the market approaches the second half of 2026, venture capital deployment in clinical A